Skip to main content

Balyasny Asset Management — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

42
Companies
$3.7B
Total invested
$100.0M
Avg. check
51
Industries
Biotechnology 9Therapeutics 8Medical 4Health Care 4Biopharma 3Life Science 3+45 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–42 of 42
Diagonal Therapeutics
January 2026

Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.

Biopharma · Watertown$125.0M Series B
CAMP4 Therapeutics
December 2025

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Biopharma · Cambridge$30.0M Post Ipo Equity
Ambros Therapeutics
December 2025

Ambros Therapeutics is a clinical-stage biotechnology company.

Biotechnology · Irvine$125.0M Series A
Harness
December 2025

Harness provides a software delivery platform that helps engineering teams build, deploy, and operate applications through a set of tools.

Artificial Intelligence (AI) · San Francisco$200.0M Series E
Crescent Biopharma
December 2025

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

Biotechnology · Rockville$185.0M Post Ipo Equity
Aspen Neuroscience
November 2025

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Biotechnology · San Diego$115.0M Series C
Solve Therapeutics
November 2025

Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.

Biopharma · Belmont$120.0M Series A
Tango Therapeutics
October 2025

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Biotechnology · Cambridge$197.0M Post Ipo Equity
LEXEO Therapeutics
October 2025

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

Biotechnology · New York$154.0M Post Ipo Equity
Expedition Therapeutics
October 2025

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

Biotechnology · San Francisco$165.0M Series A
Flyhomes
July 2025

Flyhomes provides a real estate brokerage platform that helps clients through the entire home buying process.

Financial Services · Seattle$15.0M Series D
Farmers Business Network
July 2025

Farmers Business Network is a digital marketplace that helps farmers buy inputs, access financing, and join marketing programs.

Agriculture · San Francisco$50.0M Series Unknown
Bright Machines
June 2024

Bright Machines brings together flexible factory robots with intelligent software, production data and machine learning.

Computer · San Francisco$106.0M Series C
MasterClass
July 2021

MasterClass is a provider of an online education platform designed to offer video based vocational courses.

Blockchain · San FranciscoSecondary Market
DOOR
June 2021

DOOR provides integrated hardware and software solutions.

Apps · New York$190.0M Post Ipo Equity
Cuebiq
January 2021

Cuebiq provides location intelligence and measurement company.

Advertising · ManhattanDebt Financing
Zola
May 2020

Zola is a wedding company that reinvents the wedding planning and registry experience.

E-Commerce · New YorkSeries D
Tencent Music Entertainment
January 2019

Tencent Music Entertainment Group is an online music entertainment platform that operates popular and innovative music apps.

Internet · ShenzhenPost Ipo Equity

Where Balyasny Asset Management invests

Biotechnology9
Therapeutics8
Medical4
Health Care4
Biopharma3
Life Science3

About Balyasny Asset Management's portfolio

How many companies has Balyasny Asset Management invested in?▸

Balyasny Asset Management has invested in 42 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Balyasny Asset Management invest in?▸

Balyasny Asset Management's top investment sectors include Biotechnology, Therapeutics, Medical, Health Care, Biopharma. The firm invests across 51 different industry categories.

What is Balyasny Asset Management's largest investment?▸

Among tracked funding rounds, Harness received $200.0M in a Series E round. Balyasny Asset Management's total known invested capital is $3.7B.

What is the average investment size for Balyasny Asset Management?▸

Balyasny Asset Management's average investment size is $100.0M across its portfolio of 42 companies.

What are Balyasny Asset Management's most recent investments?▸

Recent Balyasny Asset Management portfolio additions include Diagonal Therapeutics, CAMP4 Therapeutics, Ambros Therapeutics, Harness, Crescent Biopharma. These companies were founded in 2020 or later.

Reach the founders behind these 42 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →